2025 results above expectations. Solid outlook for 2026

On February 20, 2026 Orano reported full year 2025 results.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

(Press release, Orano, FEB 20, 2026, View Source;orano-2025-annual-results.pdf?sfvrsn=5930d0ab_6&_gl=1*e5n7cs*_gcl_au*NzAxOTk4OTY3LjE3ODQyMTIxNzc. [SID1234669262])